CXCL13
CXCL13 Molekülinformation
| Englischer Name | C-X-C motif chemokine 13 | Anzahl der inverkehr gebrachten Arzneimittel | 0 |
| Anzahl der klinischen Arzneimittel | 0 | Target-Alias | BCA-1，B cell-attracting chemokine 1 |
| Höchste Forschungs- und Entwicklungsphase | Preclinical | ||
| Englischer Name | C-X-C motif chemokine 13 |
| Target-Alias | BCA-1，B cell-attracting chemokine 1 |
| Anzahl der inverkehr gebrachten Arzneimittel | 0 |
| Anzahl der klinischen Arzneimittel | 0 |
| Höchste Forschungs- und Entwicklungsphase | Preclinical |
CXCL13 Produktliste
- Attribut
Protein (1)
- Produktbibliothek
Online (1)
- Spezies
Human (1)
- Etikett
His Tag (1)
- Marker
Unconjugated (1)
| Produktnummer | Spezies | Expressionssystem | Produktbeschreibung | Proteinstruktur | Reinheit | Eigenschaften | Vorbestellen/Bestellen |
|---|---|---|---|---|---|---|---|
 Human | E. coli | Human CXCL13 / BCA-1 Protein, His Tag |  |  |  In den Warenkorb legen |
Gesamtmenge1
- 1
CXCL13 Molekülhintergrund
CXCL13, originally known as BLC (B-lymphocyte chemoattractant) or BCA-1 (B cell-attracting chemokine 1), is a homeostatic chemokine. It is constitutively secreted by stromal cells in B-cell areas of secondary lymphoid tissues (follicles), such as spleen, lymph nodes, tonsils, and Peyer's patches. CXCL13 plays a key role in orchestrating cell migration within spatially distinct regions of the secondary lymphoid organs. It strongly attracts B lymphocytes while promoting migration of only small numbers of T cells and macrophages. CXCL13 exerts its functions through its receptor CXCR5, which initially, was isolated from Burkitt Lymphoma and therefore designated as Burkitt's lymphoma receptor 1 (BLR1).
CXCL13 Molekülalias
C-X-C motif chemokine 13,Angie,B cell-attracting chemokine 1,BCA-1,B lymphocyte chemoattractant,CXC chemokine BLC,Small-inducible cytokine B13,CXCL13,BCA1,BLC,SCYB13
- Molekülinformation
- Produktliste